229 related articles for article (PubMed ID: 33835220)
1. Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance.
Bezzi C; Mapelli P; Presotto L; Neri I; Scifo P; Savi A; Bettinardi V; Partelli S; Gianolli L; Falconi M; Picchio M
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4002-4015. PubMed ID: 33835220
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract][Full Text] [Related]
3. Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings.
Malcolm JA; Tacey M; Gibbs P; Lee B; Ko HS
Eur Radiol; 2023 Oct; 33(10):6659-6669. PubMed ID: 37079029
[TBL] [Abstract][Full Text] [Related]
4. CT and MRI of pancreatic tumors: an update in the era of radiomics.
Bartoli M; Barat M; Dohan A; Gaujoux S; Coriat R; Hoeffel C; Cassinotto C; Chassagnon G; Soyer P
Jpn J Radiol; 2020 Dec; 38(12):1111-1124. PubMed ID: 33085029
[TBL] [Abstract][Full Text] [Related]
5. Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions.
Cingarlini S; Ortolani S; Salgarello M; Butturini G; Malpaga A; Malfatti V; DʼOnofrio M; Davì MV; Vallerio P; Ruzzenente A; Capelli P; Citton E; Grego E; Trentin C; De Robertis R; Scarpa A; Bassi C; Tortora G
Pancreas; 2017 Jan; 46(1):42-47. PubMed ID: 27906872
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance.
Lee NJ; Hruban RH; Fishman EK
Abdom Radiol (NY); 2018 Nov; 43(11):3025-3034. PubMed ID: 29594467
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios.
Konstantinoff KS; Morani AC; Hope TA; Bhosale PR; Francis IR; Yano M; Iravani A; Trikalinos NA; Itani M
Abdom Radiol (NY); 2023 May; 48(5):1843-1853. PubMed ID: 36737523
[TBL] [Abstract][Full Text] [Related]
8. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
[TBL] [Abstract][Full Text] [Related]
9. CT-Based Radiomics Score for Distinguishing Between Grade 1 and Grade 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
Bian Y; Jiang H; Ma C; Wang L; Zheng J; Jin G; Lu J
AJR Am J Roentgenol; 2020 Oct; 215(4):852-863. PubMed ID: 32755201
[No Abstract] [Full Text] [Related]
10. Preoperative Prediction of G1 and G2/3 Grades in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging.
Liu C; Bian Y; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Lu J; Xu J; Shao C
Acad Radiol; 2022 Apr; 29(4):e49-e60. PubMed ID: 34175209
[TBL] [Abstract][Full Text] [Related]
11. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors.
Kulali F; Semiz-Oysu A; Demir M; Segmen-Yilmaz M; Bukte Y
Diagn Interv Imaging; 2018 May; 99(5):301-309. PubMed ID: 29258825
[TBL] [Abstract][Full Text] [Related]
12. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
[TBL] [Abstract][Full Text] [Related]
13. Computed Tomography Features Predictive of Lymph Node Involvement in Patients With a Nonfunctioning Pancreatic Neuroendocrine Tumor.
Choi SH; Kim HJ; Kim SY; Byun JH; Kim KW; Song KB; Kim SC; Kim MH
Pancreas; 2017 Sep; 46(8):1056-1063. PubMed ID: 28787330
[TBL] [Abstract][Full Text] [Related]
14. CT Radiogenomic Characterization of the Alternative Lengthening of Telomeres Phenotype in Pancreatic Neuroendocrine Tumors.
McGovern JM; Singhi AD; Borhani AA; Furlan A; McGrath KM; Zeh HJ; Bahary N; Dasyam AK
AJR Am J Roentgenol; 2018 Nov; 211(5):1020-1025. PubMed ID: 30160983
[TBL] [Abstract][Full Text] [Related]
15. Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms.
Loi S; Mori M; Benedetti G; Partelli S; Broggi S; Cattaneo GM; Palumbo D; Muffatti F; Falconi M; De Cobelli F; Fiorino C
Phys Med; 2020 Aug; 76():125-133. PubMed ID: 32673824
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification.
Khanna L; Prasad SR; Sunnapwar A; Kondapaneni S; Dasyam A; Tammisetti VS; Salman U; Nazarullah A; Katabathina VS
Radiographics; 2020; 40(5):1240-1262. PubMed ID: 32795239
[TBL] [Abstract][Full Text] [Related]
18. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
[TBL] [Abstract][Full Text] [Related]
19. State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review.
Ghezzo S; Bezzi C; Presotto L; Mapelli P; Bettinardi V; Savi A; Neri I; Preza E; Samanes Gajate AM; De Cobelli F; Scifo P; Picchio M
Crit Rev Oncol Hematol; 2022 Jan; 169():103544. PubMed ID: 34801699
[TBL] [Abstract][Full Text] [Related]
20. The Impact of
Cuthbertson DJ; Barriuso J; Lamarca A; Manoharan P; Westwood T; Jaffa M; Fenwick SW; Nuttall C; Lalloo F; Prachalias A; Pizanias M; Wieshmann H; McNamara MG; Hubner R; Srirajaskanthan R; Vivian G; Ramage J; Weickert MO; Pritchard DM; Vinjamuri S; Valle J; Yip VS
Front Endocrinol (Lausanne); 2021; 12():654975. PubMed ID: 34163434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]